View in EDS HTML Full Text PDF Full Text

Acute degradation of nucleolin reveals its novel functions in cell cycle progression and cell division in triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Acute degradation of nucleolin reveals its novel functions in cell cycle progression and cell division in triple negative breast cancer.
Authors: Mills J; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, 43210, USA., Tessari A; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Oncology Unit, AULSS5 Polesana, Rovigo, 45100, Italy., Anastas V; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Graduate School of Biomedical Sciences, Tufts University, Boston, MA, 02155, USA., Sunilkumar D; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA., Samadi Rad N; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, 43210, USA., Lamba S; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA., Cosentini I; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Current address: Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), Palermo, Italy., Reers A; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Current address: Department of Ecology and Evolutionary Biology, Tulane University, New Orleans, LA, 70118, USA., Zhu Z; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.; Chemistry Graduate Program, The Ohio State University, Columbus, OH, 43210, USA., Miles WO; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA., Coppola V; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus, OH, 43210, USA., Cocucci E; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, 43210, USA., Magliery TJ; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus, OH, 43210, USA., Shive H; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, 43210, USA.; Current Address: Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Davies AE; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, 43210, USA.; Current address: Division of Oncological Sciences, Department of Pediatrics, Cancer Early Detection Advanced Research Center, School of Medicine, Oregon Health and Science University, Portland, OR, 97239, USA., Rizzotto L; Gene Editing Shared Resource, The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, 908 Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH, 43210, USA., Croce CM; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA., Palmieri D; Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA. dario.palmieri@osumc.edu.; The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, OH, 43210, USA. dario.palmieri@osumc.edu.; Gene Editing Shared Resource, The Ohio State University Wexner Medical Center and Comprehensive Cancer Center, 908 Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH, 43210, USA. dario.palmieri@osumc.edu.
Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Jul 14; Vol. 44 (1), pp. 204. Date of Electronic Publication: 2025 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1756-9966
DOI:10.1186/s13046-025-03401-y